Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohtesh Mehta

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Bone Marrow Transplantation|August 26, 2024
Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host diseaseCurtis M Marcoux, Amin M Alousi, Jin Im, et al.
American Journal of Hematology|August 18, 2020
Clonal evolution and treatment outcomes in hematopoietic neoplasms arising in patients with germline RUNX1 mutationsCurtis Lachowiez, Sarah Bannon, Sanam Loghavi, et al.
British Journal of Haematology|March 22, 2021
Outcomes of lenalidomide retreatment with novel triplet regimens in patients with multiple myeloma progressing on lenalidomide-based maintenance therapyChutima Kunacheewa, Lei Feng, Elisabet E Manasanch, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 25, 2024
Azacitidine Post-transplant Maintenance Improves Disease Progression in High-Risk Acute Myeloid Leukemia and Myelodysplastic SyndromeOren Pasvolsky, Rima M Saliba, Uday R Popat, et al.
Bone Marrow Transplantation|November 18, 2018
Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugsLohith Gowda, Mithun Shah, Ifra Badar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 14, 2019
Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell TransplantationPiyanuch Kongtim, Omar Hasan, Jorge Miguel Ramos Perez, et al.
Bone Marrow Transplantation|March 26, 2021
Outcomes in patients with CRLF2 overexpressed acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantationPaul Koller, Rima M Saliba, Celina Ledesma, et al.
Blood|October 21, 2016
KIR gene haplotype: an independent predictor of clinical outcome in MDS patientsKate Stringaris, David Marin, A John Barrett, et al.
Transplantation and Cellular Therapy|November 19, 2024
Corrigendum to 'Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation' [Transplantation and Cellular Therapy 29/3 (2023) 204-204]Mansour Alkhunaizi, Badar Patel, Luis Bueno, et al.
Transplantation and Cellular Therapy|December 12, 2022
Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell TransplantationMansour Alkhunaizi, Badar Patel, Luis Bueno, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|August 26, 2024
Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host diseaseCurtis M Marcoux, Amin M Alousi, Jin Im, et al.
American Journal of Hematology|August 18, 2020
Clonal evolution and treatment outcomes in hematopoietic neoplasms arising in patients with germline RUNX1 mutationsCurtis Lachowiez, Sarah Bannon, Sanam Loghavi, et al.
British Journal of Haematology|March 22, 2021
Outcomes of lenalidomide retreatment with novel triplet regimens in patients with multiple myeloma progressing on lenalidomide-based maintenance therapyChutima Kunacheewa, Lei Feng, Elisabet E Manasanch, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 25, 2024
Azacitidine Post-transplant Maintenance Improves Disease Progression in High-Risk Acute Myeloid Leukemia and Myelodysplastic SyndromeOren Pasvolsky, Rima M Saliba, Uday R Popat, et al.
Bone Marrow Transplantation|November 18, 2018
Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugsLohith Gowda, Mithun Shah, Ifra Badar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 14, 2019
Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell TransplantationPiyanuch Kongtim, Omar Hasan, Jorge Miguel Ramos Perez, et al.
Bone Marrow Transplantation|March 26, 2021
Outcomes in patients with CRLF2 overexpressed acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantationPaul Koller, Rima M Saliba, Celina Ledesma, et al.
Blood|October 21, 2016
KIR gene haplotype: an independent predictor of clinical outcome in MDS patientsKate Stringaris, David Marin, A John Barrett, et al.
Transplantation and Cellular Therapy|November 19, 2024
Corrigendum to 'Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation' [Transplantation and Cellular Therapy 29/3 (2023) 204-204]Mansour Alkhunaizi, Badar Patel, Luis Bueno, et al.
Transplantation and Cellular Therapy|December 12, 2022
Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell TransplantationMansour Alkhunaizi, Badar Patel, Luis Bueno, et al.
Pageof 5